Related references
Note: Only part of the references are listed.CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease
Kuti Baruch et al.
NATURE MEDICINE (2016)
Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease
Yang Xiang et al.
ACTA NEUROPATHOLOGICA (2015)
Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease
Jane A. Driver et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease
Erdinc Dursun et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Broad targeting of resistance to apoptosis in cancer
Ramzi M. Mohammad et al.
SEMINARS IN CANCER BIOLOGY (2015)
DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice
Elsa Suberbielle et al.
NATURE COMMUNICATIONS (2015)
IFN-γ and TNF-α Are Involved During Alzheimer Disease Progression and Correlate with Nitric Oxide Production: A Study in Algerian Patients
Mourad Belkhelfa et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
A reduced risk of Alzheimer's disease is associated with the majority of cancers in a national cohort of veterans
Laura Frain et al.
Alzheimers & Dementia (2013)
Nonmelanoma skin cancer is associated with reduced Alzheimer disease risk
Robert S. White et al.
NEUROLOGY (2013)
Alzheimer disease controls cancer - Concerning the apoptogenic interaction of cell membrane-standing type-1 VDAC and amyloid peptides via GxxxG motifs
Friedrich P. Thinnes
MOLECULAR GENETICS AND METABOLISM (2012)
Why cancer survivors have a lower risk of Alzheimer disease
Friedrich P. Thinnes
MOLECULAR GENETICS AND METABOLISM (2012)
Aβ Potentiates Inflammatory Activation of Glial Cells Induced by Scavenger Receptor Ligands and Inflammatory Mediators in Culture
P. Murgas et al.
NEUROTOXICITY RESEARCH (2012)
Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study
Jane A. Driver et al.
BRITISH MEDICAL JOURNAL (2012)
High sensitivity to carcinogens in the brain of a mouse model of Alzheimer's disease
J. Serrano et al.
ONCOGENE (2010)
Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid β-peptide by the liver
Chihiro Tamaki et al.
PHARMACEUTICAL RESEARCH (2006)
Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer's disease brain
MD Martin-Rehrmann et al.
NEUROTOXICITY RESEARCH (2005)
Systemic catabolism of Alzheimer's Aβ40 and Aβ42
J Ghiso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Secretion and accumulation of Aβ by brain vascular smooth muscle cells from AβPP-Swedish transgenic mice
J Frackowiak et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Apolipoprotein E influences amyloid-beta clearance from the murine periphery
E. Hone et al.
JOURNAL OF ALZHEIMERS DISEASE (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Brain to plasma amyloid-β efflux:: a measure of brain amyloid burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
SCIENCE (2002)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)